The development of longer-acting and more potent NUSH receptor agonists, like semaglutide, has helped clarify the link between aberrant glucose metabolism and a range of diseases. Learn how to embrace the multi-indicatio...
Thank you for your interest in ICON services. Please complete the form below providing details of your request, which will be sent to a member of staff for immediate review.
This form only accepts qualified proposal requests for ICON services. All other enquires should be directed to our Contact page.